Public Company News

Celltrion receives U.S. FDA approval for EYDENZELT® (aflibercept-boav), biosimilar referencing EYLEA® (aflibercept)

* EYDENZELT® is approved for the treatment of patients with neovascular (wet) age-related macular degeneration (wAMD), macular edema following retinal vein occlusion (RVO), diabetic macular edema (DME), and diabetic retinopathy (DR) * Celltrion plans to enter the U.S. ophthalmology market to m...

2025-10-10 06:56 2673

Amcor Appoints Stephen R. Scherger as Executive Vice President and Chief Financial Officer

Michael Casamento to return home to Australia to be closer to his family on a full-time basis; Will leave the Company as a result, remaining in an advisory role untilJune 30, 2026 to support transition Company reaffirms Fiscal 2026 and first quarter Fiscal 2026 outlook ZURICH, Oct. 9, 2025 /PRNe...

2025-10-10 04:30 3025

POMDOCTOR LIMITED Announces Closing of Initial Public Offering

GUANGZHOU, China, Oct. 9, 2025 /PRNewswire/ -- POMDOCTOR LIMITED (Nasdaq: POM) (the "Company" or "POMDOCTOR"), a leading online medical services platform for chronic diseases inChina, today announced the closing of its initial public offering (the "Offering") of 5,000,004 American Depositary Shar...

2025-10-10 04:05 2360

LEIFRAS Co., Ltd. Announces Listing on the Nasdaq Capital Market in the U.S.

TOKYO, Oct. 9, 2025 /PRNewswire/ -- LEIFRAS Co., Ltd. (Nasdaq: LFS) (the "Company" or "Leifras"), a sports and social business company dedicated to youth sports and community engagement, today announced that its American Depository Shares ("ADSs") will commence trading on the Nasdaq Capital Marke...

2025-10-09 21:00 2576

Health In Tech Showcases Enhanced eDIYBS Platform at SIIA 2025, Accelerating Broker Growth and Market Reach

STUART, Fla.Oct. 9, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, will showcase its groundbreaking Enhanced Do It Yourself Benefit System (eDIYBS) at the upcoming SIIA National Conference, being held October 12–14, 2025 at th...

2025-10-09 19:30 2221

Samsung Biologics Introduces Optimized Manufacturing Framework, ExellenS™

* ExellenS TM applies optimized facility designs, equipment, and processes across all sites to ensure equivalency and speed * ExellenS TM combines the company's commitment to operational excellence with its core manufacturing competencies, guided by standardization, simplification, and scalab...

2025-10-09 19:00 2034

Advantech AOM-5721 Combines SMARC Design and Qualcomm Dragonwing™ QCS6490 for Next-Gen Edge AI

TAIPEI, Oct. 9, 2025 /PRNewswire/ -- Advantech (TWSE: 2395), a global leader in edge computing and AI solutions, is proud to announce the launch of the AOM-5721, a SMARC-based Arm Computer-on-Module powered by the Qualcomm® Dragonwing™ QCS6490 SoC. By combining Advantech's expertise in compact, ...

2025-10-09 17:05 1367

Acer Reports September Consolidated Revenues of NT$29.53 Billion, Highest in 11 Years; Up 35.4% Month-on-month and 12.2% Year-on-year

TAIPEI, Oct. 9, 2025 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced its consolidated revenues for September atNT$29.53 billion, marking the highest in 11 years for the same period, with growth of 12.2% year-on-year (YoY) and 35.4% month-on-month. Third quarter consolidated revenues reachedNT$73...

2025-10-09 16:33 2019

EDAN Expands U.S. Operations with New Manufacturing Hub

Facility marks EDAN's 30th anniversary and kickstarts global supply chain ecosystem SAN DIEGO, Oct. 8, 2025 /PRNewswire/ -- Edan Instruments, Inc. (300206.SZ), a global leader in medical device innovation, announced the official opening of its new U.S. manufactu...

2025-10-09 06:53 1489

Locksley Reports High-Grade Antimony Concentrate at Significantly Higher Grades than Comparable American Projects in Initial Metallurgical Test Work of Surface Samples from the Company's Desert Antimony Mine Project in California

SAN BERNARDINO, Calif., Oct. 8, 2025 /PRNewswire/ -- Locksley Resources, (ASX: LKY; OTCQB: LKYRF) announced that the company's advancing metallurgical test work program being conducted on surface samples collected from the Desert Antimony Mine (DAM) Prospect at the company's project in the Mojave...

2025-10-08 20:40 2468

POMDOCTOR LIMITED Announces Pricing of Initial Public Offering

GUANGZHOU, China, Oct. 8, 2025 /PRNewswire/ -- POMDOCTOR LIMITED (the "Company" or "POMDOCTOR"), a leading online medical services platform for chronic diseases inChina, today announced the pricing of its initial public offering (the "Offering") of 5,000,004 American Depositary Shares ("ADSs") at...

2025-10-08 20:00 1906

Dialogue on AI & Cyber Governance in the Physical AI Era: Tuya Smart Delivers Strategic Insights on Emerging Global AI Cybersecurity Paradigms

LONDON, Oct. 8, 2025 /PRNewswire/ -- As the physical AI transformation gains rapid momentum, "The Dialogue on AI & Cyber Governance" kicks off inLondon, focusing on the pressing theme of "The New Reality of Corporate AI Security." Tuya Smart (NYSE: TUYA, HKEX: 2391), a global AI cloud platform ser...

2025-10-08 14:05 1937

CARsgen Presents Results on GPRC5D CAR-T CT071 in The Lancet Haematology

SHANGHAI, Oct. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the results of CT071 (an autologous CAR T-cell product targeting GPRC5D) for the treatment of relapsed/refractory mul...

2025-10-08 08:15 1604

EPWK Holdings Ltd. Announces Pricing of $8 Million Public Offering

XIAMEN, China, Oct. 7, 2025 /PRNewswire/ -- EPWK Holdings Ltd. (Nasdaq: EPWK) (the "Company"), a company that connects businesses with great talents through innovative and efficient cloud-sourcing platforms, today announced that it has priced a best-efforts public offering with gross proceeds to ...

2025-10-07 21:00 2215

Massimo Group Launches New Sentinel 570 HVAC UTV, Expanding Premium Sentinel Series

Sentinel 570 Utility Terrain Vehicle Delivers Comfort, Connectivity and Performance with Premium Design and 4WD Capability GARLAND, Texas, Oct. 7, 2025 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO), a powersports vehicles manufacturer and distributor, today announc...

2025-10-07 20:30 1502

Kazia Therapeutics Announces Collaboration and In-Licensing Agreement for First-in-Class PD-L1 Protein Degrader Program

SYDNEY, Oct. 7, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced an exclusive collaboration and in-licensing agreement (the "Agreement") with QIMR Berghofer for a first-in-class PD-L1 degrader program. The lead optimized...

2025-10-07 20:30 2164

Yiren Digital Launches Next-Gen Magicube Agent Platform Targeting $30 Billion Generative AI Market

BEIJING, Oct. 7, 2025 /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), an AI-powered platform providing a comprehensive suite of financial services inAsia, announced a significant update to its Magicube Agent Platform, a proprietary multi-agent artificial intelli...

2025-10-07 19:57 3516

Boqii Holding Limited Provides Response to Unusual Market Action

SHANGHAI, Oct. 6, 2025 /PRNewswire/ -- Boqii Holding Limited ("Boqii" or the " Company") (NYSE American: BQ), a leading pet-focused platform in China, announced today that the Company had become aware of unusual trading activity in its Class A ordinary shares on the NYSE American LLC (the "NYSE Am...

2025-10-06 20:00 2045

Quhuo's Hotel and Home Services Sector Collaborates with Trust Plan to Explore Industry-Finance Synergies and Enhance Long-Term Rental Property Value

BEIJING, Oct. 6, 2025 /PRNewswire/ -- Quhuo Limited (NASDAQ: QH) ("Quhuo" or the "Company"), a leading gig economy platform focusing on local community-centered services inChina, today announced that its subsidiary, Lailai Information Technology (Shenzhen) Co., Ltd. ("Lailai"), specializing in h...

2025-10-06 20:00 1865

FDA Lifts Clinical Hold on NUZ-001

Highlights: * U.S. FDA lifts the Clinical Hold on NUZ‑001, Neurizon®'s lead investigational therapy for ALS * Clears the way for entry into the HEALEY ALS Platform Trial expected to commence in Q4 CY2025 * IND supported by robust preclinical safety data and comprehensive manufacturing and ...

2025-10-06 14:06 1880
1 ... 51525354555657 ... 774

Week's Top Stories